Fairview Hospital

Cleveland, Ohio 44111-5612

6 studies enrolling now · 26 studies all time

What they study most

Atrial Fibrillation, Atrial Flutter, Avascular Necrosis, Breast Cancer, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Cesarean Delivery, Colorectal Cancer, Congenital Hip Dysplasia, Failure to Thrive, Fallopian Tube Neoplasms, Follicular Lymphoma

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — Recruiting now
• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer — Recruiting now
• Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy — Recruiting now
• Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients — Recruiting now
• Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial — Running, not enrolling
• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma — Running, not enrolling
• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
• Improving Postamputation Functioning by Decreasing Phantom Pain With Perioperative Continuous Peripheral Nerve Blocks: A Department of Defense Funded Multicenter Study — Running, not enrolling
• A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery — Stopped early
• IC-CS Risk: Patient Outcomes — Running, not enrolling
• A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE) — Completed
• Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF) — Completed
• A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery — Completed
• Impact of Home Weight Tele-monitoring on the Number of Office Visits in the First Six Weeks of Life in Infants. — Completed
• Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System — Stopped early
• A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn — Completed
• EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries — Stopped early
• Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery — Completed
• Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty — Completed
• Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer — Completed
• Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination — Completed
• Ohio Colorectal Cancer Prevention Initiative — Completed
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed
• Interventions to Decrease Anxiety in Patients Undergoing Urodynamic Testing — Completed